Modhnú roghnach agus lipéadú fluaraiseachta sioncrónaithe ar pheptídí ina bhfuil N-críochfort ina bhfuil glicín: uirlisí nua chun taighde eolaíochta beatha a shoilsiú

Modhnú roghnach agus lipéadú fluaraiseachta sioncrónaithe ar pheptídí ina bhfuil N-críochfort ina bhfuil glicín: uirlisí nua chun taighde eolaíochta beatha a shoilsiú


Peptides are important participants in life activities, and their specific modification and labeling are essential for studying their structure and function. Over the past decade, methods have been developed to label glycine on α-carbon. However, these methods require pre-functionalization of glycine, which is not possible for rapid recognition of natural amino acids.In this study, we report the dual activation of the α-methylene of glycine, which distinguishes this glycine from 19 other amino acids.

Technical Advantages

Specific selectivity, utilizing the unique chemical properties of N-terminal glycine to realize its specific reaction with modifying reagents and avoid the interference of other amino acid residues.

  • Universal: Applicable to a wide range of N-terminal glycine-containing peptides, as well as different modification groups and fluorescent dyes.
  • Wide range of applications: Provide a powerful tool for peptide structure and function studies, drug screening, bio-imaging and other fields.


This study provides a method for selective labeling of N-terminal glycine peptides using 1,3-diphenyl 1,3-diones to provide pyrrole-based fluorescent products. It is strictly selective for N-terminal glycine due to the “dual activation” mechanism. It provides a theoretical basis for customized N-glycine-based fluorescence modification and a stability test method for rapid identification of N-terminal glycine-containing peptides.

admin Avatar

Bingyan Gao

Quality and Analytical Technician Core Expertise: Separation and identification of trace impurities, HPLC/MS method development, chiral purity analysis, and compliance with international pharmacopoeias.

Profile: Bingyan Gao is the “ultimate gatekeeper” of peptide purity and quality. He is proficient in the use of various high-end analytical instruments and specializes in developing customized chromatographic separation methods for highly complex modified peptides. He has established a rigorous impurity profiling system that not only ensures product purity of 99% or higher but also precisely identifies and eliminates trace impurities that could cause immunogenicity. With a deep understanding of FDA and EMA regulatory requirements for peptide drugs, he ensures that every batch released from the facility is accompanied by a comprehensive and authoritative Certificate of Analysis (COA).

Fact Checked & Editorial Guidelines
Reviewed by: Subject Matter Experts
Share this article
Baile Cuardach Whatsapp Seirbhísí Táirge